FilingReader Intelligence
Navamedic completes dne pharma acquisition for NOK225m
July 17, 2025 at 04:51 PM UTC•By FilingReader AI
Navamedic has completed the acquisition of dne pharma's business for up to NOK225 million, with NOK185 million paid at closing. The deal integrates addiction treatment products including Ventizolve and methadone, enhancing Nordic and European market access.
The acquisition was financed through NOK110 million in new debt from Nordea and a rights issue.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
OSL:NAVA•Oslo Stock Exchange
News Alerts
Get instant email alerts when Navamedic ASA publishes news
Free account required • Unsubscribe anytime